바이오테크 보도자료
-
- Philip Morris International Announces Agreement to Acquire Fertin Pharma
- Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on ora...
- 2021년 07월 02일
-
- LG Chem Announces Topline Results of LC350189 From the Phase 2 Study (CLUE Study) Promising to Be a New Treatment Alternative With Improved Efficacy and Safety Profiles for Chronic Gout Patients
- LG Chem announced topline results for the phase 2 study evaluating the efficacy and safety profiles of LC350189, a novel non-purine xanthine oxidase inhibitor for the chronic management of hyperuricemia in patients with gout disease. LG Chem had r...
- 2021년 07월 02일
-
- Ferring Pharmaceuticals Announces Changes to Board of Directors
- Ferring Pharmaceuticals announced today that Frederik Paulsen is stepping down from his role as Chairman of the Board of Directors[*] and transitioning to the role of Honorary Chairman. Lars Rebien Sørensen is appointed Chairman of the Board of Di...
- 2021년 07월 02일
-
- Anterra Capital Announces $175 Million Initial Closing of Second Global Food and Agriculture Technology Fund
- Anterra Capital (“Anterra”), the international food and agriculture specialist venture capital firm, today announced the initial closing of its second food and agriculture technology fund, Anterra F&A Ventures II, raising $175 million, exceeding t...
- 2021년 07월 02일
-
- SpeeDx and MolGen Announce Partnership for COVID-19 Test Solution
- SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The partnership links specimen handling, nucleic acid ...
- 2021년 07월 01일
-
- Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2020
- Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2021 (the “Annual Report”) with the U.S. Securities and Exchange Commission (...
- 2021년 06월 30일
-
- Ferring Presents New Data at ESHRE 2021 Supporting the Use of Rekovelle® (follitropin delta) for Individualized Fertility Treatment
- New data, presented today at the 37th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), show a comparable ongoing pregnancy rate of 31.3% with the individualised dosing regimen of Rekovelle, compared to 25.7% wit...
- 2021년 06월 30일
-
- Covetrus Introduces New Roles and Leadership Within Its North America & Global Businesses
- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced the appointments of Bekki Kidd and András Bolcskei to the roles of head of North America Operations & Global Operational Excellence and president of Inte...
- 2021년 06월 29일
-
- Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States
- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, and Galderma, the world’s largest independent dermatology company, today announced they have signed two exclusive 5-year license agreements for the commercialization ...
- 2021년 06월 29일
-
- Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute
- Waters Corporation (NYSE:WAT) today announced an expansion of its joint work with the Bioprocessing Technology Institute (BTI), a research institute of Singapore's Agency for Science, Technology and Research (A*STAR). Among their new collaborative...
- 2021년 06월 28일
-
- Invivoscribe Launches Grant Program to Support Novel Applications for Sequence-Based Analyses of the Immune System
- Invivoscribe, a global leader in precision diagnostics, has announced the launch of an Immune Biomarker Discovery grant program, focused on supporting development, validation and deployment of novel applications for use of their distributed Lympho...
- 2021년 06월 25일
-
- Abbas Hussain Appointed as New Chief Executive Officer of Vifor Pharma
- Regulatory News: Abbas Hussain (56, British citizen) has a successful and international career of more than 30 years as an executive in the healthcare sector. From 2008 to 2017, Abbas Hussain held various leadership positions for the British pharm...
- 2021년 06월 25일
-
- Vifor Pharma to revise DIAMOND study, readout expected in H2 2021
- Regulatory News: Vifor Pharma Group today announced that the phase-IIIb DIAMOND study has been amended with new and clinically relevant endpoints, including a new primary endpoint of efficacy in potassium management in high-risk heart failure pati...
- 2021년 06월 25일
전시회
